ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 1

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Reviews

1. The Prelude on Novel Receptor and Ligand Targets Involved in the Treatment of Diabetes Mellitus

Venu Gopal Jonnalagadda*, Allam Venkata Sita Ram Raju, Srinivas Pittala, Afsar Shaik, Nilakash Annaji Selkar

Adv Pharm Bull. 2014;4(3): 209-217. doi: 10.5681/apb.2014.031

PMCID: PMC3992955 PMID: 24754003 Scopus ID: 84983573763

Article

PDF

XML

Cited By:

Research Article

2. Evaluating Effect of Mesenchymal Stem Cells on Expression of TLR2 and TLR4 in Mouse DCs

Mohammad Hossein Karimi, Zahra Barzkar, Maryam Babaee, Majid Naghdi*

Adv Pharm Bull. 2016;6(2): 179-186. doi: 10.15171/apb.2016.025

PMCID: PMC4961975 PMID: 27478779 Scopus ID: 84980327276

Article

PDF

XML

Cited By:

Review Article

3. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics

Rehmat Jan , Gul-e-Saba Chaudhry*

Adv Pharm Bull. 2019;9(2): 205-218. doi: 10.15171/apb.2019.024

PMCID: PMC6664112 PMID: 31380246 Scopus ID: 85066810537

Article

PDF

XML

Cited By:

247

160

494

Research Article

4. Contribution of Lysosome and Sigma Receptors to Neuroprotective Effects of Memantine Against Beta-Amyloid in the SH-SY5Y Cells

Mojtaba Keshavarz* , Majid Reza Farrokhi , Elahe Amirinezhad Fard , Mohammad Mehdipour

Adv Pharm Bull. 2020;10(3): 452-457. doi: 10.34172/apb.2020.055

PMCID: PMC7335986 PMID: 32665905 Scopus ID: 85088617195

Article

PDF

Full Text

XML

Cited By:

Review Article

5. Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies

Sherin Joseph , Anila Kutty Narayanan*

Adv Pharm Bull. 2022;12(1): 34-44. doi: 10.34172/apb.2022.005

PMCID: PMC9012918 PMID: 35517888 Scopus ID: 85127157166

Article

PDF

Full Text

XML

Cited By:

Review Article

6. CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy

Behrouz Shademan , Vahidreza Karamad, Alireza Nourazarian, Cigir Biray Avcı*

Adv Pharm Bull. 2022;12(3): 476-489. doi: 10.34172/apb.2022.051

PMCID: PMC9348524 PMID: 35935042 Scopus ID: 85123831502

Article

PDF

Full Text

XML

Cited By:

Original Article

7. Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric Adenocarcinoma

Maryam Samareh-Salavatipour , Shirin Tavakoli , Maryam Barkhordar, Iman Seyhoun*, Nasim Vousooghi, Mohammad Vaezi, Afshin Ghaderi, Tahereh Bakhtiari, Ardeshir Ghavamzadeh, Javad Verdi* , Mohammad Ahmadvand*

Adv Pharm Bull. 2025;15(1): 143-153. doi: 10.34172/apb.43859

Article

PDF

XML

Cited By: